Eisai Inc.

This study is testing whether adding a medicine called perampanel to a child's current seizure medications helps reduce how often they have seizures. It will involve about 100 children, from 1 month to under 18 years old, who have epilepsy and are still having frequent seizures. …

This study is testing a new drug called MORAb-202 in people with advanced ovarian, endometrial, lung, or triple-negative breast cancer. The main goals are to find a safe dose and see if the drug can shrink tumors. The drug is designed to target cancer cells specifically, and some…

This is the first study to test a new oral drug called E1018 in people. Researchers will give single, increasing doses to 32 healthy adults to check for safety and see how the body absorbs and eliminates the drug. The goal is to gather initial data to see if the drug is safe enou…

This early-stage study aims to understand how the body breaks down and eliminates the experimental drug E2086. Ten healthy male volunteers will receive a single, traceable dose. Researchers will measure how much of the drug is absorbed, how long it stays in the body, and how it i…